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Abstract
Glycogen in glial cells is the largest store of glucose equivalents in the brain. Here we describe evidence that brain glycogen
contributes to aerobic energy metabolism of the guinea pig brain in vivo. Five min after an intra-arterial bolus injection of
D-[U-14C]glucose, 28 þ 11% of the radioactivity in brain tissue was associated with the glycogen fraction, indicating that a
significant proportion of labelled glucose taken up by the brain is converted to glycogen shortly after bolus infusion.
Incorporation of 13C-label into lactate generated by brains made ischaemic after D-[1-13C]glucose injection confirms that
these glucose equivalents can be mobilised for anaerobic glucose metabolism. Aerobic metabolism was monitored by
following the time course of 13C-incorporation into glutamate in guinea pig cortex and cerebellum in vivo. After an intra-
arterial bolus injection of D-[1-13C]glucose, glutamate labelling reached a maximum 40^60 min after injection, suggesting that
a slowly metabolised pool of labelled glucose equivalents was present. As the concentration of 13C-labelled glucose in blood
was shown to decrease below detectable levels within 5 min of bolus injection, this late phase of glutamate labelling must
occur with mobilisation of a brain storage pool of labelled glucose equivalents. We interpret this as evidence that glucose
equivalents in glycogen may contribute to energy metabolism in the aerobic guinea pig brain. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Glycogen (0.6^1.6 mg/g wet wt. in the guinea pig
brain[1]) is the single biggest carbohydrate energy
store in the brain [2], with the majority of glycogen
found in astrocytes [3]. Metabolism of glucose equiv-
alents of glycogen for lactate synthesis during ischae-
mia and hypoxia is well-known [4]. However, brain
glycogen concentration also varies with synaptic ac-
tivity, e.g. it increases during barbiturate-induced
anaesthesia [5]. Swanson [6] has shown that there is
direct coupling of glial glycogen metabolism to neu-
ronal activity, and release of speci¢c neurotransmit-
ters promotes glycogenolysis [7]. Although a tradi-
tional view has been that glycogen is metabolically
inactive under normal conditions in vivo, radiotracer
studies suggest there is substantial turnover of la-
belled glycogen in the well-perfused, normoxic state
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[1]. Poitry-Yamate and colleagues [8] suggested that
Mu«ller cells found in the guinea pig retina export
glycogen-derived lactate to neurones to support en-
ergy metabolism.
In the present study, the labelling of metabolites
was followed in the guinea pig brain using isotope-
labelled glucose as a tracer compound. Relative glu-
cose £ux into the brain glycogen fraction was tested
and then label incorporation into lactate was used as
an index of anaerobic metabolism of glucose equiv-
alents in glycogen. In order to test the hypothesis
that brain glycogen also contributes to the energy
metabolism of the well-perfused guinea pig brain in
vivo, the distribution of 13C-label in glutamate was
followed with 13C- and 1H- high resolution NMR
after intra-arterial infusion of D-[1-13C]glucose.
2. Materials and methods
2.1. Materials
D-[1-13C]glucose (99.9%), D-[U-14C]glucose and
[13C]formate (99%) were purchased from Cambridge
Isotope Laboratories, Andover, MA, USA. Opti-
solve was obtained from LKB Scintillation Products
(Loughborough, UK). Cytoscint scintillation £uid
was purchased from ICN (Costa Mesa, CA, USA).
All other reagents were of AR grade.
2.2. Methods
2.2.1. Metabolism of D-[1-13C]glucose by guinea pig
cortex and cerebellum in vivo
All experiments were conducted within the welfare
for animals guidelines of the United Kingdom Home
O⁄ce.
Guinea pigs (Hartley), fed ad libitum prior to the
procedure, were anaesthetised with fentanyl/£uani-
sone (Hypnorm) and midazolam (Hypnovel) by in-
tramuscular injection (0.2 ml/kg of Hypnorm fol-
lowed 10 min later with 1 mg/kg of Hypnovel) and
a cannula was inserted into the left carotid artery.
The cannula was inserted upstream (i.e. in the direc-
tion of the heart). The vascular anatomy is such that
£uid injected upstream into the left carotid artery
enters the brachiocephalic trunk and is then forced
to enter the right carotid artery or the right subcla-
vian artery. This method was adopted due to the
tendency of the delicate guinea pig artery to collapse
when high concentrations of glucose were injected in
a downstream direction.
Blood glucose both before and after the adminis-
tration of the bolus of glucose was measured using
an ExacTech blood glucose pen (MediSense, Wal-
tham, USA). The duration of the injection of the
bolus was less than 10 s. A toe-nail was clipped to
provide the blood sample for blood glucose testing.
Resting blood glucose levels for the guinea pig were
found to be 3.7 þ 0.5 mM and had reached a level of
6.0 þ 0.9 mM 5 min after the administration of the
bolus. At subsequent time points, the blood glucose
was found to lie in the range 3.8 þ 0.8 mM.
To study metabolism in the presence of anaesthe-
sia, a solution of D-[1-13C]glucose in physiological
saline (20% w/v, 0.15 mg/g b.wt.) was infused within
10 s. The guinea pig was sacri¢ced by cervical dis-
location at either 5, 10, 20, 30, 40 or 60 min post-
infusion (n = 3), and the cortex and cerebellum rap-
idly dissected out and frozen in liquid nitrogen (less
than 15 s from death to complete freezing). For the
awake animal study (n = 3, except at 30 and 40 min
where n = 4), the cannula was passed beneath the
skin to emerge at the back of the neck and the
wound sutured during anaesthesia. Systemic analge-
sia was used to minimise discomfort (45 Wg/kg bu-
prenorphine).
The animal was allowed to recover from anaes-
thesia for at least 18 h. During recovery, topical
lignocaine was used as a local anaesthetic to mini-
mise discomfort at the wound site. A solution of D-
[1-13C]glucose was then infused into the cannula as
above. Frozen tissue samples were extracted, neutral-
ised and lyophilised as above. Protein estimations
were performed on the pellet obtained after tissue
extraction with perchloric acid using the method of
Miller [9].
Following sacri¢ce, 5 ml of blood was removed
and immediately placed in an equal volume of
perchloric acid, extracted and freeze-dried as above.
No residual 13C-label was detected in 13C-NMR
spectra of blood extracts from any time point. On
some occasions, the liver was also dissected, freeze-
clamped and extracted. Only trace amounts of 13C-
label were detected in 13C-NMR spectra obtained of
liver extracts.
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2.2.2. Metabolism of D-[U-14C]glucose by guinea pig
cortex and cerebellum in vivo
To investigate the fate of the bolus of glucose (as
NMR detection of 13C is less sensitive compared
with radioisotope detection of 14C), infusions of
D-[U-14C]glucose were carried out in three anaesthe-
tised guinea pigs in an identical manner to those
described above. A bolus of solution containing
D-glucose (20% w/v, 0.15 mg/g b.wt.) labelled with
20 WCi of D-[U-14C]glucose in physiological saline
was infused. The animals were sacri¢ced after
20 min by cervical dislocation and the brain and
5 ml of blood were removed. Tissue was dissolved
in Optisolve (200 mg of tissue to 1 ml of optisolve) at
60‡C, diluted four-fold in Cytoscint and radioactivity
was measured using a LS 1701 Scintillation Counter
(Beckman, UK).
To investigate whether glycogen was labelled after
an infused bolus of D-[U-14C]glucose, animals were
anaesthetised and cannulated as above (n = 6). The
skin above the skull was removed, and a bolus con-
taining D-glucose (20% w/v 0.15 mg/g b.wt.) labelled
with 20 WCi of D-[U-14C]glucose in physiological sal-
ine was administered within 10 s. Five minutes after
the administration of the bolus, the brain was frozen
by pouring liquid nitrogen through a funnel onto the
skull. The brain was removed and sections dissolved
in KOH (40 mg of tissue to 0.5 ml of 1 M KOH) by
heating for 20 min at 70‡C. Samples of the dissolved
tissue were counted for radioactivity in the manner
described above. Glycogen was precipitated from
other tissue samples dissolved in KOH using ice-
cold ethanol by the method described by Stau¡acher
and Renold [10] and Cuendet and co-workers [11].
Precipitated glycogen was redissolved in water and
reprecipitated in ice-cold ethanol to ensure that glu-
cose and glucose-6-phosphate were removed from the
fraction. The fraction may, however, still have con-
tained some amount of long chain polysaccharide
carbohydrates other than glycogen. The pellet was
dissolved in water and the radioactivity of the
sample was examined in the manner described above.
However, while we have found that this procedure
gives acceptably precise measurements, we suspect
that it may underestimate the total labelled glycogen
content in brain. The assay was developed as a gen-
eral method for glycogen estimation in tissues and
optimised for skeletal muscle, in which glycogen
may be more stable during the extraction than in
brain.
Label incorporation is expressed as a percentage of
the injected radioactivity per gram wet weight of tis-
sue.
2.2.3. Acquisition of NMR spectra
Lyophilised samples were resuspended in D2O
containing 4 mM [13C]formate as an internal inten-
sity and chemical shift reference and dispensed into
5 mm NMR tubes. All 1H-NMR spectra were ac-
quired at 400.12 MHz on a Varian INOVA spec-
trometer (Varian Associates, Palo Alto, CA) across
32K data points using a repetition period of 30 s for
‘fully relaxed’ spectra. Free-induction decays were
transformed using zero-¢lling from 32K to 64K
data points and an exponential multiplication factor
of 0.5 Hz. Peak assignment was aided by reference to
standard spectra of authentic compounds.
All 13C-NMR spectra were acquired at 100.61
MHz across 128K data points using a repetition pe-
riod of 3.485 s with broad-band proton decoupling
(WALTZ-16 [12]) during the acquisition time. Free-
induction decays were transformed using zero-¢lling
from 128K to 256K data points and an exponential
multiplication factor of 3 Hz. Peak assignment was
aided by reference to standard spectra of authentic
compounds. Peak areas were determined using stand-
ard Varian software (version 5.2f). The concentration
of isotopomers was calculated by multiplying peak
areas by a saturation factor obtained from fully re-
laxed spectra which allowed for spin-relaxation and
nuclear Overhauser e¡ect (n.O.e), and comparing
this with the area of an internal concentration stand-
ard. The combined e¡ect of spin-relaxation and
n.O.e di¡ered markedly for the three resonances of
glutamate with the pulse sequence used. Thus, a di-
rect comparison of intensities of glutamate resonan-
ces cannot be performed without use of correction
factors Spectra were also obtained of tissue extracts
in the absence of any 13C-label in order to compen-
sate for natural abundance contributions. Metabolite
enrichment is expressed as an absolute measure of
micromoles 13C-label incorporated per gram wet
weight of tissue extracted.
2.2.4. Estimation of metabolic pool sizes
The concentrations of glutamate, glutamine and
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lactate in cortex and cerebellum extracts were esti-
mated for each time point using 1H-NMR. Peak
areas were determined from fully relaxed spectra
for glutamate (Q-CH2), glutamine (Q-CH2) and lactate
(CH3) and compared with the reference peaks of for-
mate (n = 12; two for each time point).
2.2.5. Analysis of the labelling of metabolites by
D-[1-13C]glucose
During the metabolism of D-[1-13C]glucose gluta-
mate and glutamine are labelled at di¡erent positions
depending on the pathway involved (Fig. 1). Pyru-
vate dehydrogenase is found in both glia and neuro-
nes. Glutamate and glutamine derived from label en-
tering the tricarboxylic acid (TCA) cycle via this
enzyme will be labelled at the C4 position on the ¢rst
turn of the cycle and then with equal probability at
the C2 and C3 positions on the second turn. How-
ever, glutamate and glutamine derived from label
entering the tricarboxylic acid cycle via the glial-
only enzyme pyruvate carboxylase are labelled at
the C2 position. Thus, the quantity of glutamate
derived via anaplerosis (pyruvate carboxylase
pathway) on the ¢rst turn of the cycle is given by
the di¡erence between C2 and C3 labelling of gluta-
mate provided only two turns of the TCA cycle are
considered. Shank and co-workers [13] de¢ned the
anaplerotic ratio (R) for glutamate, an approximate
measure of the contribution of anaplerosis compared
to the catabolic pathway in the amino acid’s produc-
tion as
R  C2 glu3C3 glu=C4 glu 1
where [Cx glu] indicates the concentration of Cx-la-
belled glutamate. However, R is time-dependent and
becomes a less accurate measure (underestimating
the true proportion of anaplerosis) of the amount
of glutamate produced by anaplerosis at longer times
after labelling.
2.2.6. Statistical analysis
Data are expressed as mean þ S.D. Statistical anal-
ysis was performed using Student’s unpaired, two-
tailed t-test. Di¡erences in mean values were consid-
Fig. 1. The labelling pattern of metabolites by 13C from the metabolism of D-[1-13C]glucose depends on the pathways involved. Glu-
cose is metabolised by glycolysis to produce an equal quantity of unlabelled and [3-13C]pyruvate. Subsequent metabolites are labelled
at di¡erent positions depending on whether [3-13C]pyruvate is a substrate for pyruvate dehydrogenase or the glial-only enzyme pyru-
vate carboxylase, as well as how many turns of the TCA cycle occur before the metabolite is labelled. Considering glutamate and glu-
tamine, the carbon backbone is labelled at the C4 position on the ¢rst turn of the cycle via pyruvate dehydrogenase and then at the
C2 and C3 position with equal probability on the second turn. The C2 position is also labelled via pyruvate carboxylase. Thus, the la-
belling pattern is indicative of the relative rate of activity of the enzymes pyruvate carboxylase and pyruvate dehydrogenase. For sim-
plicity, only the pyruvate carboxylase pathway products are shown for glia. Key: PC, pyruvate carboxylase; PDH, pyruvate dehydro-
genase; GABA-T, GABA transaminase; GAD, glutamic acid decarboxylase; 2-Oxoglu, 2-oxoglutarate; OAA, oxaloacetate; Glu,
glutamate; Gln, glutamine. * 13C-label.
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ered statistically signi¢cant at P6 0.05. For the
awake brain an ANOVA test analysis was per-
formed, with a test for non-linearity using InStat
for Macintosh (GraphPad software) to judge
whether any time points were considered signi¢-
cantly di¡erent from the trend detected in 13C-label-
ling.
3. Results
3.1. Brain glycogen incorporates labelled glucose after
an intra-arterial bolus injection
To investigate whether a bolus injection of D-[U-
14C]glucose is incorporated into brain glycogen, the
relative incorporation of D-[U-14C]glucose into the
brain homogenate glycogen fraction was measured.
To limit ischaemic production of lactate from glyco-
gen during tissue extraction, funnel freezing of the
brain was used. Five min after intra-arterial injection
of a bolus of glucose containing trace amounts of
D-[U-14C]glucose, 28 þ 11% (n = 6) of the label in
the brain was found in the glycogen fraction.
3.2. Labelled glucose is cleared rapidly from the blood
after bolus injection
The time course of 14C-labelled glucose in the
blood after intra-arterial injection of a glucose bolus
(0.15 mg of glucose/g b.wt.) with trace amounts of D-
[U-14C]glucose (20 WCi) was followed to de¢ne the
distribution of label in the guinea pig. At 20 min
after injection, only 1.03 þ 0.03% (n = 3) of the
total injected label was still present in blood
(0.027 þ 0.001%/g wet wt. of tissue, where wet weight
has been calculated assuming 65 ml of blood/kg of
guinea pig b.wt.). If all of the label was present in
glucose (which must overestimate the labelled glu-
cose as metabolites of glucose such as lactate also
are present in the blood), then the enrichment of
the blood with label at 20 min would be 0.035 at
maximum (assuming normal plasma glucose concen-
tration (3.7 mM)). Such a low speci¢c activity of
serum glucose could give a maximum enrichment
of brain lactate and glutamate of only 0.018 þ 0.001.
A 1.3 þ 0.2% amount of the injected radioactivity
was found in brain (0.39 þ 0.01%/g wet wt. of tissue).
Assuming that 28% of this label was still associated
Fig. 2. Fully relaxed 400.12 MHz 1H-spectrum of an extract from an awake guinea pig cortex following 40 min of metabolism of
D-[1-13C]glucose. The resonances of Q-glutamine, Q-glutamate and CH3 lactate were used to calculate the total extractable amount of
metabolite found in the extract. The 13C-sideband resonances for CH3 lactate were used to calculate the total concentration of
[3-13C]lactate detected and cross checked with calculations from 13C-spectra. Key to 1H-resonances: 1, L/LP-glutamate/glutamine; 2,
CH3 N-acetyl aspartate; 3, Q-GABA; 4, L-alanine; 5, 13C-sidebands of CH3 lactate; 6, CH3 lactate; 7, L/LP-aspartate; 8, LP-N-acetyl
aspartate/aspartate; 9, L-N-acetyl-aspartate/aspartate; 10, Q-glutamine; 11, Q-glutamate; 12, L-GABA; p.p.m., parts per million.
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with the glycogen fraction at 20 min (glycogen con-
tent was measured at 5 min post-infusion), infusion
of a 90-mg bolus of glucose should produce V0.33
mg or 1.8 Wmol of labelled glucosyl units.
3.3. Labelled glucose equivalents incorporated into
glycogen are used for anaerobic metabolism
during agonal ischaemia
Brain extracts were prepared after a period of ago-
nal ischaemia induced by decapitation. 13C-NMR
spectra were used to measure label incorporation
into lactate. The C3 labelling of lactate re£ects the
prior label incorporation into glycogen, free glucose
and lactate prior to death in the brain. The label
incorporation into C3 lactate decreased with increas-
ing time from the glucose bolus injection and to
sacri¢ce. With decapitation at 5 min after bolus in-
jection, C3 labelled lactate concentration was
0.60 þ 0.11 Wmol/g wet wt. and 0.42 þ 0.13 Wmol/g
wet wt. for the cortex and cerebellum, respectively.
In the cortex, labelling of lactate was reduced by
58 þ 12% with a 60-min delay between bolus injection
and decapitation. Given the rapid decrease in blood
glucose speci¢c activity, the 13C-label in lactate at
60 min must predominantly re£ect label incorpora-
tion into glycogen.
3.4. Glucose equivalents in glycogen are metabolised
aerobically in the awake animal
In order to determine the speci¢c enrichment of
individual metabolites with 13C-label, the total con-
centrations of glutamate, glutamine and lactate were
measured in rapidly frozen extracts using 1H-NMR
and label incorporation into metabolites was meas-
ured using 13C-NMR (Figs. 2 and 3, Table 1). Label-
ling of the excitatory amino acid glutamate was used
as a probe to monitor metabolism of
D-[1-13C]glucose in the aerobic brain in vivo. After
bolus injection of D-[1-13C]glucose, the amino acids
glutamate, aspartate and glutamine were labelled
Fig. 3. 1H-Decoupled 13C-spectra of extracts from awake cortex (A) and cerebellum (B) after 30 min of metabolism of D-[1-
13C]glucose. Note that occasionally [1-13C]glucose was detected. However, for any given sample, enrichment was less than 0.01 (assum-
ing free glucose concentration V1.6 Wmol/g wet wt. [1]) and when averaged over all samples at no time point was the labelling signi¢-
cantly di¡erent from spectra obtained of brain tissue labelled by 13C at natural abundance. The region from 10 to 100 ppm is shown.
Resonances are relative to the internal standard [13C]formate resonance at 172 ppm. Key (chemical shifts as parts per million (ppm)
in parentheses) : 1, C1 glucose (93.2 and 97.0 for K- and L-anomers); 2, C1^C6 inositol; 3, C2 lactate (69.6); 4, C2 glutamate (55.8);
5, C2 glutamine (55.4); 6, C2 N-acetyl aspartate (54.0); 7, C2 aspartate (53.4); 8, C2 alanine (51.7); 9, C2 GABA (40.1); 10, C3 as-
partate (37.8) ; 11, C4 GABA (35.1) ; 12, C4 glutamate (34.6) ; 13, C4 glutamine (32.0); 14, C3 glutamate (28.3); 15, C3 glutamine
(27.5), 16, C3 lactate (21.0).
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readily in both the cortex and the cerebellum (Fig. 3).
The dominant resonance was from C4 glutamate.
New label incorporation into glutamate occurred
in the cortex and the cerebellum over more than 40
min. There was a trend suggesting an early phase of
labelling with a maximum between 20 and 30 min
with a relative glutamate C4 enrichment of
0.016 þ 0.003 and 0.026 þ 0.004 in the cortex and cer-
ebellum, respectively (Fig. 4). The later labelling
peak occurred between 40 and 60 min with an en-
richment of 0.035 þ 0.04 and 0.050 þ 0.015 in gluta-
mate in the cortex and cerebellum, respectively. The
labelling at the C4 position of brain glutamate at 40^
60 min was signi¢cantly greater than the linear trend
for the ¢rst four time points (F = 10.8, P6 0.001,
ANOVA), suggesting that there were two distinct
phases of labelling. A similar time course of label
incorporation was seen for the C2 and C3 glutamate
positions.
In both the cerebral cortex and the cerebellum the
anaplerotic ratio (Eq. 1 (a measure of the relative
£ux through glial-localised pyruvate carboxylase as
opposed to pyruvate dehydrogenase) increased sub-
stantially after about 30 min following the bolus in-
fusion (Fig. 5). By 60 min, 13 þ 4% and 33 þ 6% of
the glutamate synthesis occurred via the anaplerotic
pathway in the cortex and cerebellum, respectively.
3.5. Anaesthesia delays labelling of C4 glutamate
The maximum C4 labelling in the cerebral cortex
was achieved earlier in the awake than in the anaes-
thetised animal (P = 0.03 at 40 min) (Fig. 6).
3.6. Low glutamine enrichment demonstrates that the
delayed labelling of glutamate does not arise from
glutamine
To investigate the possibility that the delayed glu-
tamate labelling may be due to new synthesis of glu-
tamate from labelled glutamine, the time course of
Fig. 4. The 13C-labelling pattern of glutamate with time in the
awake guinea pig cortex and cerebellum. Mean þ S.D. (n = 3, ex-
cept for t = 30 min, 40 min where n = 4). In the cortex and cere-
bellum, the 13C-labelling of glutamate was biphasic for the C2,
C3 and C4 positions. C4 glutamate labelling dominated the la-
belling pattern. There was a signi¢cant di¡erence between C2
and C3 labelling of glutamate after 40 min for the cortex and
cerebellum, indicating substantial production of glutamate via
pyruvate carboxylase. Key: q, C4 glutamate; u, C2 glutamate;
m, C3 glutamate.
Table 1
The total extractable concentration of certain metabolites found
in cortical and cerebellar extracts in the awake and anaesthe-
tised guinea pig
Metabolite concentration Awake Anaesthetised
Cortex
Lactate 15.8 þ 4.6 10.5 þ 2.8a
Glutamate 13.0 þ 3.2 8.1 þ 2.7b
Glutamine 5.3 þ 2.1 4.3 þ 1.0
Cerebellum
Lactate 15.9 þ 4.7 8.2 þ 2.3c
Glutamate 11.5 þ 4.1 8.2 þ 2.3
Glutamine 7.4 þ 3.5 2.4 þ 1.0a
Concentrations of these metabolites were not found to vary
with time after the introduction of the bolus of D-[1-13C]glucose
and means are from averages of all time points (two for each
time point; n = 12 unless stated). Values are mean þ S.D. Wmol/
100 mg of protein.
aP6 0.05
bP6 0.005
cP6 0.001 for signi¢cant di¡erence between the awake and
anaesthetised animal in either the cortex or the cerebellum, cal-
culated using Student’s unpaired t-test.
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enrichment and labelling pattern of glutamine was
determined. In both the cortex and cerebellum, C4
glutamine was the most highly labelled glutamine
resonance (Fig. 7). However, the relative enrichment
of glutamine in both the cortex (maxi-
mum = 0.020 þ 0.007) and the cerebellum (maxi-
mum = 0.027 þ 0.008) of awake animals was always
lower than that observed for glutamate, implying
that a major fraction of the labelled glutamate
must have been derived from an alternative pathway.
4. Discussion
Lowry and co-workers [4] observed that there is a
rapid increase in lactate concentration post-mortem
that is accompanied by a decrease in glycogen con-
tent of the brain. Here we also found that lactate
concentrations in the cortical and cerebellar extracts
prepared by decapitation from awake animals were
10-fold greater than values quoted for the normal
range in vivo (0.8^2.0 mM [1]). Estimates of free
glucose concentration [1] suggest that only 20% of
the lactate detected could have arisen directly from
brain glucose, suggesting that the majority of the
lactate was derived from glycogen. As the speci¢c
enrichment of the lactate by 13C-label was at least
2^3-fold greater than could be accounted for by the
serum glucose enrichment, glucose equivalents in the
Fig. 6. The 13C-labelling pattern of glutamate with time in the
anaesthetised guinea pig for the cortex and cerebellum.
Mean þ S.D. (n = 3). A biphasic labelling of glutamate occurred
in the anaesthetised cerebellum, although unlike the awake ani-
mal, the second phase of labelling was delayed until 60 min. In
the anaesthetised cortex, labelling of glutamate appeared to rise
almost constantly with time. Key: q, C4 glutamate; s, C2 gluta-
mate; m, C3 glutamate.
Fig. 5. The anaplerotic ratio for glutamate production in the
cortex and cerebellum for the awake and anaesthetised guinea
pig. Mean þ S.D. (n = 3, except for t = 30 min, 40 min where
n = 4). The anaplerotic ratio measures the relative rate of label-
ling of a metabolite via the glial-only enzyme pyruvate carboxy-
lase to that produced via pyruvate dehydrogenase. Key: q,
awake animal; s, anaesthetised animal.
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brain glycogen pool labelled after the intra-arterial D-
[1-13C]glucose injection therefore must contribute
substantially. This inference was supported by direct
demonstration of incorporation of D-[U-14C]glucose
in the brain glycogen fraction after bolus intra-arte-
rial injection.
Unlike lactate, glutamate concentrations and label-
ling in brain extracts accurately re£ect concentrations
in the brain in vivo [13,14] (both the TCA cycle and
glutamate dehydrogenase are rapidly inhibited by the
increases in NADH/NAD ratio in the mitochondria
that occur during hypoxia/ischaemia [15]). An earlier
study of cerebral metabolism of intraperitoneally in-
jected D-[1-13C]glucose in rat brains failed to demon-
strate a di¡erence in glutamate and glutamine label-
ling between brain tissue left for 2 min or rapidly
frozen [13]. Glutamate post-mortem appears to be
remarkably stable, with Petro¡ and colleagues re-
porting only a small increase in brain pool size 1 h
post-mortem in the rabbit [14].
Despite the rapid fall in serum labelled glucose, a
signi¢cantly delayed time course for labelling of glu-
tamate with 13C at the C4 position was observed in
both the cortex and cerebellum of the awake animal.
Shank and colleagues [13] previously suggested that
there may be a biphasic labelling pattern of cerebral
glutamate following the injection of a bolus of D-[1-
13C]glucose in the rat, but they did not comment on
its possible signi¢cance. Their results were consistent
with rapid labelling over the ¢rst 5 min after bolus
injection, followed by slower labelling to reach a
maximum label incorporation after 45 min. In our
study, the later phase of glutamate labelling was ac-
companied by an increase in the synthesis of gluta-
mate by anaplerotic pathways, suggesting that there
was a relative increase in contribution of metabolites
in glial cells (as pyruvate carboxylase is compartmen-
talised in glia [16]).
The apparent biphasic time course for labelling of
glutamate at the C4 position suggests that there may
be at least two pools of D-[1-13C]glucose equivalents.
The pool contributing most to the earliest phase of
labelling is likely to be derived directly from blood
glucose. Previous work has demonstrated that la-
belled substrates introduced as a single bolus either
subcutaneously or by intracarotid injection predom-
inantly label the brain on the ¢rst circulation [17,18].
The labelling of glutamate in this early phase occurs
with little anaplerosis, suggesting that the precursor
labelled glucose equivalent is metabolised predomi-
nantly by neurones [13,19]. The signi¢cant delay be-
tween bolus injection and maximum C4 glutamate
labelling in our experiments demonstrates that a pro-
portion of the label is not directly incorporated into
the TCA cycle immediately following the bolus. This
suggests that there is an intermediate store of labelled
Fig. 7. The 13C-labelling of glutamine at the C4 position com-
pared with that of its precursor C4 glutamate. Mean þ S.D.
(n = 3, except for t = 30 min, 40 min where n = 4 in the awake
cortex and cerebellum). In both the awake and anaesthetised
cerebellum, the labelling of glutamine and glutamate at the C4
position was very similar in pattern, showing biphasic labelling.
However, in the cortex, no biphasic labelling of glutamine at
the C4 position was observed in either the awake or the anaes-
thetised animal. Key: q, C4 glutamate; l, C4 glutamine.
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glucose equivalents that is released for metabolism
more slowly.
The concentration and enrichment of free glucose
in the brain is determined by the concentration and
enrichment of plasma glucose [20,21]. We have
shown directly that the speci¢c enrichment of plasma
glucose was too low to account for the later phase of
glutamate labelling. This later phase of glutamate
label incorporation also cannot be accounted for by
synthesis from glutamine, which had a lower speci¢c
activity than did the glutamate.
Almost 30% of the bolus of labelled glucose iso-
lated from the guinea pig brain was found in the
glycogen fraction initially after the bolus injection.
This suggests that 13C-labelled glucose equivalents
in glycogen are a potential precursor of the newly
synthesised, labelled glutamate. The multi-chain, pol-
ymeric structure of glycogen (from which the most
recently added glucose equivalents would be hydro-
lysed) would allow the speci¢c activity of metabolites
derived from glycogen soon after incorporation of
new label could be highly enriched relative to the
mean speci¢c enrichment of the total glycogen
pool. Thus, after a labelled glucose bolus, even a
modest contribution of glucose equivalents from
brain glycogen to synthesis of glutamate could en-
hance glutamate speci¢c activity substantially.
Brain glycogen is predominantly found in glia
[4,8]. The higher anaplerotic ratio for glutamate syn-
thesised during the second phase of labelling is con-
sistent with a higher contribution from glial-derived
precursors to the total labelled glutamate precursor
pool. There is substantial evidence that glial glycogen
is metabolised to labelled lactate for export [22,23]
and that it is glial-derived lactate that is used directly
as a substrate for neurones [24^27]. This could, in
part, explain the delay between bolus infusion and
peak C4 glutamate labelling.
In contrast to our results obtained after bolus in-
jection, a biphasic labelling pattern for glutamate
was not observed in previous studies employing
steady-state infusions of D-[1-13C]glucose into the
brain (e.g. [28,29]). However, as steady-state infu-
sions of labelled substrate maintain a high, constant
serum speci¢c activity, such experiments should not
be expected to be sensitive to the contribution from
any less highly labelled intracellular pool. It also is
possible that an intra-arterial bolus infusion of glu-
cose may stimulate brain glycogen synthesis if there
is a transiently high cytoplasmic free glucose concen-
tration as a result of equilibration of cytoplasmic and
serum glucose.
It has long been recognised that brain glycogen is
a substrate for anaerobic glycolysis in the brain dur-
ing hypoxia and ischaemia [3]. However, these ex-
periments suggest that brain glycogen also may pro-
vide a dynamic store of glucose which can be in
constant use in the well-perfused brain. There is a
growing literature that glial glycogen content is af-
fected by neuronal activity [8,30]. It is possible that
provision of glucose equivalents from glycogen
(rather than directly from glucose) is favoured kineti-
cally during periods of higher metabolic rate (e.g.
during functional activation) in a fashion similar to
Ca2-induced mobilisation of glucose equivalents
from glycogen in skeletal muscle during contraction
[31]. Some of this may occur directly in neurones.
However, the increase in the anaplerotic ratio for
glutamate during the later phase of labelling is con-
sistent with the notion that neuronal oxidative me-
tabolism may rely, to a signi¢cant extent, on release
of lactate generated from the metabolism of glial
glycogen.
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